Medicenna Therapeutics Corp
(MDNAF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 2,952 | 2,966 | 3,508 | 4,052 | 3,317 |
| Operating Income | -2,952 | -2,966 | -3,508 | -4,052 | -3,317 |
| Other Income | 294 | -7,353 | -147 | 1,277 | 1,188 |
| Pre-tax Income | -2,658 | -10,319 | -3,655 | -2,775 | -2,129 |
| Net Income Continuous | -2,658 | -10,319 | -3,655 | -2,775 | -2,129 |
| Net Income | $-2,658 | $-10,319 | $-3,655 | $-2,775 | $-2,129 |
| EPS Basic Total Ops | -0.04 | -0.16 | -0.05 | -0.04 | -0.03 |
| EPS Basic Continuous Ops | -0.04 | -0.15 | -0.05 | -0.04 | -0.03 |
| EPS Diluted Total Ops | -0.04 | -0.16 | -0.05 | -0.04 | -0.03 |
| EPS Diluted Continuous Ops | -0.04 | -0.15 | -0.05 | -0.04 | -0.03 |
| EPS Diluted Before Non-Recurring Items | -0.04 | -0.04 | -0.05 | N/A | N/A |
| EBITDA(a) | $-2,948 | $-2,965 | $-3,508 | $-4,051 | $-3,316 |